Coherus BioSciences, Inc. 4
4 · Coherus BioSciences, Inc. · Filed Mar 3, 2017
Insider Transaction Report
Form 4
Herman Alan C.
Chief Scientific Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2017-03-01$24.19/sh−11,333$274,171→ 101,785 total
Holdings
- 300,164(indirect: By Trust)
Common Stock, $0.0001 par value
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $23.85 to $24.625, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.